Wednesday, August 21, 2024 8:05:12 AM
What are you talking about see below:
Here is the chronology of the lawsuit:
December 1, 2022 NWBO filed the lawsuit. It is being represented by the highly respected Cohen Milstein law firm.
April 10, 2023 NWBO filed the First Amended Complaint
July 12, 2023 Defendants responded with a Motion to Dismiss (MTD).
November 14, 2023 Oral arguments from plaintiff and defendants were heard.
December 29, 2023 Magistrate Judge Stein oversaw this opening phase of the law suit and issued an extensive 85 page Report and Recommendation (R&R) summarizing his findings.
February 14, 2024 District Judge Woods agreed with and adopted the R&R. The R&R was overall very favorable to NWBO. It concluded that the market makers through spoofing on numerous occasions had purposely manipulated the price of NWBO to cause it to decline. Judge Woods also adopted Judge Stein’s position that NWBO had not sufficiently pled loss causation and on that basis granted the Defendants’ MTD.
Importantly, the Court allowed leave to amend the complaint on the sole issue of loss causation emphasizing that such an amendment would not be futile. In the R&R, the Court laid out a clear roadmap on how NWBO could successfully address loss causation in which case the MTD would be denied and NWBO could proceed to discovery. This Second Amended Complaint is due on, or before March 15, 2024.
Here is the chronology of the lawsuit:
December 1, 2022 NWBO filed the lawsuit. It is being represented by the highly respected Cohen Milstein law firm.
April 10, 2023 NWBO filed the First Amended Complaint
July 12, 2023 Defendants responded with a Motion to Dismiss (MTD).
November 14, 2023 Oral arguments from plaintiff and defendants were heard.
December 29, 2023 Magistrate Judge Stein oversaw this opening phase of the law suit and issued an extensive 85 page Report and Recommendation (R&R) summarizing his findings.
February 14, 2024 District Judge Woods agreed with and adopted the R&R. The R&R was overall very favorable to NWBO. It concluded that the market makers through spoofing on numerous occasions had purposely manipulated the price of NWBO to cause it to decline. Judge Woods also adopted Judge Stein’s position that NWBO had not sufficiently pled loss causation and on that basis granted the Defendants’ MTD.
Importantly, the Court allowed leave to amend the complaint on the sole issue of loss causation emphasizing that such an amendment would not be futile. In the R&R, the Court laid out a clear roadmap on how NWBO could successfully address loss causation in which case the MTD would be denied and NWBO could proceed to discovery. This Second Amended Complaint is due on, or before March 15, 2024.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
